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Available online at www.sciencedirect.comDrugs that block mechanically-evoked pain would be useful for
many common pain conditions, but appropriate drug
development targets have yet to be defined. There is increasing
evidence that both peripheral sensory neuron wiring patterns
as well as the expression of transducing molecules are
important for modality specific pain sensations. Progress in
identifying the cell types, candidate transducing molecules and
wiring patterns involved in mechanosensation has been
dramatic over the past few years. Here we focus on potential
mechano-transducing channels, and the relevant cell types
and wiring patterns that provide clues for new analgesic drug
development strategies.
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Introduction
Mechanically-evoked pain occurs in large numbers of
people who often suffer ongoing poorly treated pain.
The figures for osteoarthritis alone are staggering – most
people over the age of 55 are inhibited in their move-
ments to some extent by mechanically-evoked pain
resulting from joint wear and tear [1]. The mechanisms
of mechanotransduction and the cell types involved in
mechanosensation are thus worthy of study and this has
necessarily been carried out in animal models. A major
problem in the field of mechanically-evoked pain is the
precision of the terminology. Mechanical hyperalgesia –
sensitisation to noxious stimuli – is distinct from allodynia
where innocuous stimuli like the touch of a feather can
become painful. The cells and mechanisms involved in
these two events are probably different but there are
difficulties in modelling these events in animals. There is
agreement that squeezing the feet or tail of rodents with a
Randall–Sellito apparatus provides a noxious stimulus.
The withdrawal response from von Frey hairs is more
problematic. Some groups define von Frey withdrawalCurrent Opinion in Pharmacology 2012, 12:4–8 thresholds of a few millinewtons as noxious, even though
these stimuli are clearly not tissue damaging. As von Frey
withdrawal thresholds are reduced in conditions of
inflammatory pain, a situation of mechanical hypersensi-
tivity, the ability to distinguish allodynia from mechanical
hyperalgesia in animal behavioural models remains pro-
blematic (Figure 1).
Despite these difficulties, enormous progress has been
made in understanding aspects of mechanosensation The
specialised cell types found in the skin that are involved
in sensing touch and vibration, as well as the evidence for
subsets of sensory neurons that respond to different
mechanical stimuli has been recently reviewed [2].
First attempts to understand how sensory neurons were
activated by mechanical stimuli came from Jon Levine’s
laboratory, where mechanical stimulation of cell somata
was shown to result in inward currents [3]. The great
advantage of this system is that the cells can be voltage-
clamped so that the characteristics of mechanically gated
channels could be defined without recruiting voltage-
gated channels as a consequence of depolarisation. In
addition, the cells can be classified on the basis of their
expression of various cellular markers associated with a
particular function – for example expression of neuro-
peptides implicated in pain pathways.
In 2002 Drew et al. demonstrated that three different
types of mechanically-gated channel could be identified
in the cell bodies of sensory neurons in vitro [4]. All
neurons associated with touch and proprioreception
express low threshold rapidly adapting mechanically-
gated currents, whilst a mixed repertoire of high threshold
intermediately adapting or slowly adapting currents and
some rapidly adapting currents are associated with sen-
sory neurons that express nociceptive markers. About a
third of these neurons are mechanically insensitive using
in vitro assays. These data were later confirmed [5] in a
study of the terminals of sensory neurons in culture,
where the channels normally reside in vivo. Whether
the rapidly adapting currents in presumptive nociceptors
are the same as those in low threshold mechanoreceptors
associated with touch and proprioception is unknown.
Mechanotransducer candidates
Attempts to define the molecular nature of mechanosen-
sitive channels have used two approaches. Firstly the
behavioural and electrophysiological consequences of
deleting candidate channels in mice have been investi-
gated [6]. Secondly drug screening in an attempt to define
selective blockers that may provide tools for purificationwww.sciencedirect.com
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Mechanically activated currents in sensory neurons. Three different type of mechanically activated (MA) currents have been identified in cell bodies of
sensory neurons [4]. The MA currents differ in the rate of adaptation and have distinct pharmacological profiles. The decay kinetics of rapidly adapting
currents are best described by a bi-exponential fit, whilst intermediately adapting currents were best described by a mono-exponential fit. Activation of
slowly adapting currents is slow in comparison to the other and is described by a mono-exponential fit. Small to medium cell diameter (<45 mm)
neurons with broad action potentials that are associated with the detection of noxious stimuli display all three MA currents that have relatively high
threshold for activation. Large diameter (>45 mm) neurons with narrow action potentials are associated with touch and proprioception as display
predominantly rapidly adapting MA currents that have relatively low thresholds for activation. Displayed MA currents are representative for mouse
sensory neurons at a holding potential of 70 mV.or cloning has been carried out [7]. Genetic studies of
flies and worms have identified proteins that are bona fide
mechanically gated ion channels. Transducing ‘Mec’
channels that are members of the epithelial sodium
channel (ENaC) family have been described in C. elegans
[8]. The mammalian homologues of these channels have
been extensively investigated; none of the DRG ENac
family members have provided a compelling case as
mechanotransducers in sensory neurons [8,9]. Analysis
of single or multiple ASIC knock-out mice shows that the
mechanotransducing currents present on sensory neurons
are not diminished [6].
A stronger case can be made for TRP channels as poten-
tial mammalian mechanosensors. The worm TRP familywww.sciencedirect.com members OSM-9 and TRPA1 are involved in osmosensa-
tion and touch sensation and a role for TRP channels as
direct mechanotransducers was demonstrated in muta-
genesis studies of the TRP-4 channel, a member of the
TRPN set that is not expressed in mammals [10].
TRPV4 deletion in mice is associated with defective
responses to noxious mechanical pressure and late-onset
deafness [11]. TRPA1 is characterised by six transmem-
brane domains and has 14 N-terminal ankyrin repeats.
TRPA1 is expressed in dorsal root ganglion, trigeminal
ganglion neurons and hair cells. However hearing and
touch are apparently normal in the null mutant [12].
Interestingly however, there is increasing evidence of a
role for TRPA1 in noxious mechanosensation. The prin-
cipal sensation associated with a gain of function TRPA1Current Opinion in Pharmacology 2012, 12:4–8
6 Neurosciencesmutation in man that leads to episodic pain syndrome
(FEPS) is heavy unbearable pain conveying a feeling of
pressure [13]. Deletion of TRPA1 in mice leads to the
silencing of a set of small peptidergic sensory neurons that
mainly express slowly adapting mechanosensitive cur-
rents on mechanical stimulation, and the same mice have
behavioural deficits in response to the Randall–Sellito
apparatus that provides noxious mechanical stimulation
[14,15]. A selective blocker of TRPA1 also inhibits
mechanosensory currents in sensory neurons, and has
useful analgesic effects in terms of inhibiting mechanical
hypersensitivity in various models of pain associated with
tissue damage [16]. TRPA1 is also required for normal
mechano- and chemosensory function in specific subsets
of vagal, splanchnic, and pelvic afferents [17]. All of these
data are consistent with a role for TRPA1 as a mechani-
cally-gated ion channel, but expression of such an activity
has not yet been demonstrated using heterologous
expression of TRPA1. This may reflect either loss of
necessary accessory subunits to form the mechanotrans-
ducing complex, or the loss of a signalling molecule that is
found in sensory neurons.
Other TRP channels have also been implicated in
mechanosensation. TRPC1, C6 and TRPV4 have been
linked with mechanical hyperalgesia associated with
inflammation. Use of antisense oligonucleotides showed
that TRPC1 and TRPV4 are required for mechanical
hyperalgesia but not baseline mechanical thresholds,
whilst TRPC6 plays a role in both mechanical and ther-
mal hyperalgesia [18].
Recently two transmembrane proteins named FAM38a
and b have been shown to confer mechanosensitivity
when expressed in various cell lines [19]. These
proteins are additional candidates to mediate the stretch
activated channel activity described in many cell types
because Fam38a is blocked by GSMTX4, a tarantula
toxin that is a stretch-activated channel blocker [20].
Fam38b re-named piezo-2 is also found in sensory
neurons, where rapid inactivation kinetics make it a
candidate for a mechanosensory role in non-nociceptive
sensory neurons. In neonatal rat sensory neurons neither
rapidly nor slowly adapting mechanosensitive currents are
blocked by GSMTX4 [4], but there remains the possib-
ility that a subset of rapidly adapting currents are blocked
by the peptide in adult animals.
The behavioural consequence of deleting voltage-gated
sodium channels has suggested that they may play se-
lective role in noxious mechanosensation. The most
obvious phenotype in mice where the voltage-gated
sodium channels Nav1.7 or Nav1.8 have been deleted in
sensory neurons is insensitivity to noxious mechanical
pressure, whilst light touch is unaffected. Global deletion
of Nav1.7 leads to a loss of all pain modalities and olfaction
in both mice and men [21]. Does this suggest that theseCurrent Opinion in Pharmacology 2012, 12:4–8 sodium channels are involved in mechanotransduction? In
fact, these observations provide an insight into the wiring
patterns that are key to distinguishing different types of
pain sensation, as the mechanosensitive currents present in
sensory neurons are unaffected by sodium channel
deletion. It seems that these particular sodium channel
isoforms are specifically associated with action potential
generation in neurons that respond to mechanical damage.
Similarities between hearing and
mechanosensation
The mechanically gated channels present in sensory
neurons and cochlear hair cells both depend upon the
integrity of the actin cytoskeleton for function, suggesting
that channel tethering to the cytoskeleton occurs in both
systems [4]. Interestingly, FM1–43, a permeant inhibitor
of all sensory neuron mechanosensory currents is also a
selective blocker of cochlear hair cell mechanically-
evoked currents, suggesting that some common elements
are involved in hearing touch and pain transduction
[22,23]. In behavioural studies this compound blocks both
light touch and noxious mechanosensation, linking the
channels described in sensory neurons in culture with
mechanosensation. Fixable FM1–43 dye derivatives stain
up mechanosensitive cells in both the DRG and cochlea,
again highlighting potential similarities in mechanism in
these 2 sets of mechanosensitive cells [24].
Mediators that change mechanical pain
thresholds
Inflammatory mediators alter all pain thresholds in-
cluding those for mechanical stimuli. Dissecting mech-
anisms of mechanical sensitisation thus requires an
understanding of both general changes of excitability
as well as specific effects on mechanotransduction. It
appears that PKA mediated events act on neuronal excit-
ability rather than primary mechanotransduction, whilst
NGF and PKC mediated events can increase levels of
expression of mechanosensitive channels. NGF has
potent effects at the level of transcription on the expres-
sion of mechanosensitive ion channels in sensory neurons
in culture [25]. G-protein mediated enhancement of
mechanosensitivity by UTP and ATP that reduce
thresholds for mechanically induced action potential fir-
ing has also been described [26]. The clinically relevant
question in this area is how mechanical allodynia occurs,
and how it can be blocked, and as with many other aspects
of this area of study, the identification of the primary
mechanotransduction mechanisms is essential for this
question to be answered.
Towards mechanosensory wiring diagrams
A combination of neuronal silencing strategies, cell
depletion and gene deletion studies have provided us
with new insights into the particular cell types that
discriminate between different mechanical stimuli.
Deletion of vesicular glutamate receptors that arewww.sciencedirect.com
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mitter blocks glutamate release and silences glutama-
tergic neurons. There are 3 vesicular glutamate
transporters that are expressed in neuronal subsets of
dorsal root ganglion (DRG) neurons that transmit sen-
sory information using the excitatory transmitter glu-
tamate. Kullander deleted VGLUT2 with a Cre
recombinase driven by the Nav1.8 promoter and found
that noxious mechanical pain was specifically abolished
whilst thermal pain was unaffected. Inflammatory
mechanical hyperalgesia also depended upon this sub-
set of sensory neurons [27]. Use of a tyrosine hydroxyl-
ase Cre that deletes the transporter in a different
population of sensory neurons caused deficits in ther-
mal pain, and lead to a dramatic increase in itching [28].
Seal et al. found that a subset of neurons in mouse DRG
express the low-abundance vesicular glutamate trans-
porter VGLUT3 and project to lamina I and lamina II
in the spinal cord [29]. The deletion of the VGLUT3
gene also impaired mechanical but not thermal pain
sensation and the mechanical hypersensitivity associ-
ated with tissue damage owing to a loss of signalling
from unmyelinated, low-threshold mechanoreceptors.
Diphtheria toxin-A subunit blocks translation and kills
neurons in which it is expressed and, when driven by a
global promoter, can be unmasked by cell specific expres-
sion of a Cre recombinase. Killing all post mitotic sensory
neurons that express the sodium channel Nav1.8 leads to
a loss of responsiveness to noxious mechanical pressure
and cold as well as the heightened sensitivity to thermal
or mechanic stimuli associated with inflammatory pain
[30]. Thus the neurons that respond to low threshold
mechanical or thermal stimuli are Nav1.8 negative, whilst
those that sensitise these responses during inflammatory
pain are Nav1.8+. Similarly, Nav1.7 deletion in the
Nav1.8 population abolishes inflammatory pain and nox-
ious mechanosensation, whilst Nav1.7 expression in other
Nav1.8-neuronal populations is required for thermal pain.
Total Nav1.7 ablation causes anosmia and a pain free
state without cell death, making this an interesting target
for mechanical as well as other types of pain.
Further clues about the properties of neurons involved in
noxious mechanosensation comes from the ablation of
neurons that express the G protein-coupled receptor
Mrgprd leading to reduced behavioural sensitivity to
noxious mechanical stimuli, but not to heat or cold [31].
Other genetic approaches have exploited the expression
of growth factor receptors, combined with mapping the
terminals of sets of sensory neurons. Those cells that
express the GDNF receptor c-ret early in development
seem to be particularly interesting from the point of view
of light touch and perhaps allodynia. These cells form
neurons with rapidly adapting mechanically gated cur-
rents associated with Meissner corpuscles, and Pacinianwww.sciencedirect.com corpuscles that terminate in layers III through V of the
spinal cord and the medulla [32]
Drugs and mechanosensation
Neutralising anti-NGF monoclonal antibodies are potent
analgesics for many types of mechanically-evoked pain.
Both osteoarthritis and back pain are well treated by
reducing levels of NGF, an inflammatory mediator as
well as trophic factor involved in the development of the
peripheral nervous system. However, these drugs are on
hold because of potential serious side effect issues
possibly caused by unwitting self harm to joints during
analgesia, as a result of removing circulating NGF [1].
Small peptide blockers of mechanosensitive channels
(GSMTX4 and NMB1) provide support for the view that
different molecules are involved in stretch-activated and
slowly adapting mechanosensitive currents respectively,
but high affinity selective ligands useful for cloning or
biochemical purification strategies have not been
described. Interestingly GSMTX4 blocks mechanical
hyperalgesia, whilst NMB1 is specific for noxious mech-
anical pain [4,17]. Given the fact that mechanical hyper-
algesia can be blocked by the usual repertoire of ant-
inflammatory drugs, the most fascinating topic remains
the mechanisms involved in the establishment of allody-
nia, and how allodynia can be addressed pharmacologi-
cally. Studies of Fam38b knock-mice will be particularly
interesting in this respect.
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